[#item_full_content]
TEL AVIV & BOSTON–(BUSINESS WIRE)– #MentalHealth–Syremis Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health disorders, today announced the appointment of Aaron Koenig, MD, as Chief Medical Officer. Dr. Koenig is a psychiatrist and drug-development leader with extensive experience in both neuropsychiatric disorders and neurodegenerative diseases, including Alzheimer’s disease. “Aaron’s unique combination of frontline